Morningside Venture Investments Ltd Insider Trading Activity

Average Profitability
33.25%
Insider Buys Quantity
12
Insider Buys Sum
$121.78M
Insider Sells Quantity
29
Insider Sells Sum
$26.37M

Insider Activity of Morningside Venture Investments Ltd

Biography of Morningside Venture Investments Ltd

No biography is available at this moment.

2023-03-29SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
29,048
0.2329%
$30.45$884,512-35.56%
2023-03-28SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
100,000
0.7997%
$30.37$3.04M-38.28%
2023-03-27SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
60,964
0.4897%
$30.50$1.86M-38.07%
2023-03-21SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
63,448
0.5331%
$31.91$2.02M-37.13%
2023-03-16SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
9,122
0.0782%
$32.55$296,921-38.87%
2023-03-15SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
150,000
1.3143%
$33.27$4.99M-41.38%
2023-03-14SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
70,714
0.6432%
$34.54$2.44M-41.64%
2023-03-02SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
50,000
0.4444%
$33.75$1.69M-38.63%
2023-02-23SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
50,000
0.4683%
$35.57$1.78M-40.7%
2023-02-22SaleAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
100,000
0.9312%
$35.36$3.54M-41.92%
2022-01-11PurchaseAmylyx Pharmaceuticals, Inc.
AMLX
10 percent owner
263,158
1.3166%
$19.00$5M+23.75%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.